MagForce Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
69
- Stock Symbol
-
MF6
MagForce General Information
Description
MagForce AG is a medical engineering company. The company operates in the area of nanotechnology-based cancer treatment. Its medical devices include NanoTherm therapy used for local treatment of solid tumors, NanoTherm a liquid that reacts to the presence of a magnetic field, NanoPlan uses the bioheat transfer equation, and NanoActivator used for tumors in all areas of the body.
Contact Information
Website
www.magforce.deCorporate Office
- Max- Planck Strasse 3
- 12489 Berlin
- Germany
Corporate Office
- Max- Planck Strasse 3
- 12489 Berlin
- Germany
MagForce Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 11.6K |
MagForce Financials Summary
As of 31-Dec-2021, MagForce has a trailing 12-month revenue of $416K.
|
In Thousands, USD |
TTM 31-Dec-2021 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 120,534 | 120,534 | 203,131 | 140,512 |
| Revenue | 416 | 416 | 708 | 940 |
| EBITDA | (8,475) | (8,475) | 20,789 | (7,409) |
| Net Income | (12,502) | (12,502) | 16,810 | (9,773) |
| Total Assets | 71,137 | 71,137 | 80,676 | 41,065 |
| Total Debt | 29,032 | 29,032 | 28,075 | 18,677 |
MagForce Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MagForce Patents
MagForce Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4096624-A1 | Paste comprising magnetic alkoxysilane-coated metal containing nanoparticles | Pending | 31-Jan-2020 | ||
| WO-2021152136-A1 | Paste comprising magnetic alkoxysilane-coated metal containing nanoparticles | Inactive | 31-Jan-2020 | ||
| CA-2828139-A1 | Computer-aided simulation tool for providing assistance in the planning of thermotherapy | Active | 08-Mar-2012 | ||
| CA-2828139-C | Computer-aided simulation tool for providing assistance in the planning of thermotherapy | Active | 08-Mar-2012 | ||
| CA-2844774-A1 | Agglomerating magnetic alkoxysilane-coated nanoparticles | Active | 10-Aug-2011 | A61K41/0052 |
MagForce Signals
MagForce Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MagForce ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
MagForce FAQs
-
When was MagForce founded?
MagForce was founded in 1997.
-
Where is MagForce headquartered?
MagForce is headquartered in Berlin, Germany.
-
What is the size of MagForce?
MagForce has 69 total employees.
-
What industry is MagForce in?
MagForce’s primary industry is Diagnostic Equipment.
-
Is MagForce a private or public company?
MagForce is a Public company.
-
What is MagForce’s stock symbol?
The ticker symbol for MagForce is MF6.
-
What is MagForce’s current revenue?
The trailing twelve month revenue for MagForce is $416K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process